Table 1.
The prevalence of human leukocyte antigen (HLA) alleles in subacute thyroiditis (SAT) patients and the control group.
| HLA Allele | Subacute Thyroiditis % (No of Patients) | Healthy Controls % (No of Patients) | p-Value |
|---|---|---|---|
| HLA-B*35:01 | 38.8 (23) | 5.2 (53) | p < 0.0001 |
| HLA-B*35:02 | 11.7 (7) | 1.2 (12) | p < 0.0001 |
| HLA-B*35:03 | 35 (21) | 3.4 (35) | p < 0.0001 |
| HLA-B*35:08 | 3.3 (2) | 0.4 (4) | p < 0.0367 |
| HLA-B*35:01/02/03/08 | 81.7 (49) | 10.2 (104) | p < 0.0001 |
| HLA-B*18:01 | 23.3 (14) | 7.2 (74) | p = 0.0001 |
| HLA-C*04:01 | 75.5 (45) | 12.5 (128) | p < 0.0001 |
| HLA-DRB1*01:01 | 25 (15) | 12.0 (130) | p = 0.0126 |
| HLA-DRB1*01:02 | 1.7 (1) | 0.1 (1) | p = 0.2286 |
| HLA-DRB1*01:03 | 1.7 (1) | 0.1 (1) | p = 0.2286 |
| HLA-DRB1*01:01/02/03 | 28.3 (17) | 12.9 (132) | p = 0.007 |
| HLA-C*03 | 11.7 (7) | 10 (102) | p = 0.8386 |
| HLA-DRB1*08 | 6.7 (4) | 3.4 (35) | p = 0.3397 |